Pulmonary Tuberculosis (TB) – A Complete Medical Guide

Overview

Pulmonary tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs but can spread to other organs if untreated. TB is transmitted through airborne droplets when a person with active pulmonary disease coughs, sneezes, speaks, or sings. While many people are infected, only a minority develop active disease; the rest remain in a latent, non‑contagious state.

According to the World Health Organization, TB remains one of the top 10 causes of death worldwide, and the leading cause from a single infectious agent, surpassing HIV/AIDS.^[1]

Symptoms Checklist

• Persistent cough lasting > 3 weeks
• Chest pain or discomfort
• Hemoptysis (coughing up blood or sputum tinged with blood)
• Unexplained weight loss
• Night sweats
• Fever (often low‑grade) and chills
• Fatigue or general weakness
• Loss of appetite

Symptoms may develop slowly over weeks to months. In some cases, especially in people with weakened immune systems, they can appear more rapidly.

Risk Factors

• Close contact with someone who has active pulmonary TB
• Living or working in congregate settings (e.g., prisons, shelters, nursing homes)
• HIV infection or other conditions that weaken the immune system (e.g., diabetes, chronic kidney disease, malignancy)
• Substance abuse, especially tobacco, alcohol, or illicit drugs
• Malnutrition or low body weight
• Recent travel to or residence in regions with high TB prevalence (e.g., parts of Asia, Africa, Eastern Europe, and Latin America)
• Age extremes – children < 5 years and adults > 65 years

Diagnosis

Diagnosing pulmonary TB involves a combination of clinical assessment, imaging, and microbiologic testing:

1. Medical History & Physical Exam: Evaluation of symptoms, exposure risk, and risk‑factor profile.
2. Chest Radiograph (X‑ray): Looks for classic findings such as upper‑lobe infiltrates, cavitary lesions, or nodular patterns.^[2]
3. Sputum Microscopy: Acid‑fast bacilli (AFB) smear using Ziehl‑Neelsen staining; provides rapid, though less sensitive, results.
4. Sputum Culture: Gold‑standard for confirming TB and performing drug‑susceptibility testing; results take 2–8 weeks.
5. Nucleic Acid Amplification Tests (NAAT): Molecular assays (e.g., GeneXpert MTB/RIF) detect bacterial DNA and rifampin resistance within hours.^[3]
6. Interferon‑Gamma Release Assays (IGRAs) or Tuberculin Skin Test (TST): Identify latent infection; not used alone to diagnose active disease.

Treatment Options

Effective treatment requires a multi‑drug regimen to prevent resistance. Therapy is divided into two phases:

1. Intensive Phase (2 months)

• Isoniazid (INH)
• Rifampin (RIF)
• Pyrazinamide (PZA)
• Ethambutol (EMB) – added when drug resistance is suspected or confirmed.

2. Continuation Phase (4–7 months)

• Isoniazid + Rifampin (most common regimen)
• Alternative regimens (e.g., Rifampin‑only) may be used for patients intolerant to INH.

All medications are taken orally under direct observation (DOT) in many programs to ensure adherence.

Adjunctive & Home Care

• Nutrition support – high‑protein, calorie‑dense diet.
• Vitamin D supplementation may improve outcomes in some patients (consult your provider).
• Smoking cessation and avoidance of alcohol.
• Isolation precautions (usually 2 weeks of effective therapy) to reduce transmission.

Prevention

• BCG Vaccine: Provides variable protection against severe forms of TB in children; not routinely used in the United States.
• Infection Control: Use of N95 respirators, negative‑pressure rooms, and proper ventilation in healthcare settings.
• Screening: Targeted testing of high‑risk groups (e.g., contacts of active cases, HIV‑positive individuals).
• Latent TB Treatment: Isoniazid for 6–9 months or Rifampin for 4 months to prevent progression to active disease.
• Public Health Measures: Prompt reporting, contact tracing, and completion of therapy.

Living With Pulmonary Tuberculosis

Managing TB goes beyond medication. Below are practical tips for daily life:

• Medication Adherence: Set alarms, use pillboxes, or enroll in a DOT program.
• Follow‑up Appointments: Attend all scheduled labs and chest X‑rays to monitor response.
• Side‑Effect Monitoring: Report visual changes (possible ethambutol toxicity), liver‑related symptoms (nausea, jaundice), or peripheral neuropathy (isoniazid).
• Nutrition & Hydration: Eat balanced meals; stay well‑hydrated to help the liver process drugs.
• Rest & Activity: Gradually increase activity as energy returns; avoid strenuous exercise if you feel fatigued.
• Infection Control at Home: Keep windows open for ventilation, wear a mask when coughing, and cover mouth with a tissue.
• Emotional Support: Join support groups or counseling; TB can be socially stigmatizing.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden, severe shortness of breath or difficulty breathing
• Chest pain that worsens with breathing or coughing
• Massive coughing up of blood (more than a few teaspoons)
• High fever (> 39 °C / 102 °F) with chills that does not improve with antipyretics
• Signs of drug toxicity: severe jaundice, dark urine, persistent nausea/vomiting, or numbness/tingling in hands and feet

Medical Disclaimer: This guide is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized care. The content reflects current knowledge as of January 2026 and may not include the latest research or guidelines.

References

1. World Health Organization. Global Tuberculosis Report 2023. https://www.who.int/publications/i/item/9789240091022
2. Mayo Clinic. Tuberculosis – Symptoms & Causes.
3. Centers for Disease Control and Prevention. Nucleic Acid Amplification Tests for TB.
4. National Institutes of Health, National Institute of Allergy and Infectious Diseases. Tuberculosis (TB) Overview.
5. Cleveland Clinic. Tuberculosis (TB) Treatment.
6. Johns Hopkins Medicine. Pulmonary Tuberculosis.